| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | SLC44A2 COX15 SLC8A3 XKR4 MCUB SLC14A2 SLC35C1 ATP4B MCU RYR3 CNGB3 | 4.06e-05 | 1289 | 41 | 11 | GO:0005215 |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 8.58e-05 | 7 | 41 | 2 | GO:0005004 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC44A2 COX15 SLC8A3 MCUB SLC14A2 SLC35C1 ATP4B MCU RYR3 CNGB3 | 1.04e-04 | 1180 | 41 | 10 | GO:0022857 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 3.98e-04 | 477 | 41 | 6 | GO:0022804 | |
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 4.25e-04 | 15 | 41 | 2 | GO:0005005 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 5.49e-04 | 17 | 41 | 2 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 5.49e-04 | 17 | 41 | 2 | GO:0019198 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 6.88e-04 | 19 | 41 | 2 | GO:0005003 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 1.05e-03 | 793 | 41 | 7 | GO:0015075 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 2.09e-03 | 33 | 41 | 2 | GO:0005217 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 2.20e-03 | 664 | 41 | 6 | GO:0008324 | |
| GeneOntologyMolecularFunction | antiporter activity | 2.84e-03 | 138 | 41 | 3 | GO:0015297 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 3.11e-03 | 296 | 41 | 4 | GO:0015291 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 3.27e-03 | 145 | 41 | 3 | GO:0004713 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 3.66e-03 | 151 | 41 | 3 | GO:0015085 | |
| GeneOntologyBiologicalProcess | fasciculation of motor neuron axon | 3.67e-06 | 2 | 40 | 2 | GO:0097156 | |
| GeneOntologyBiologicalProcess | fasciculation of sensory neuron axon | 1.10e-05 | 3 | 40 | 2 | GO:0097155 | |
| GeneOntologyBiologicalProcess | mitochondrial calcium ion transmembrane transport | 1.51e-05 | 25 | 40 | 3 | GO:0006851 | |
| GeneOntologyBiologicalProcess | mitochondrial calcium ion homeostasis | 2.38e-05 | 29 | 40 | 3 | GO:0051560 | |
| GeneOntologyBiologicalProcess | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity | 1.63e-04 | 10 | 40 | 2 | GO:1990264 | |
| GeneOntologyBiologicalProcess | mitotic nuclear membrane organization | 1.63e-04 | 10 | 40 | 2 | GO:0101024 | |
| GeneOntologyBiologicalProcess | mitotic nuclear membrane reassembly | 1.63e-04 | 10 | 40 | 2 | GO:0007084 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation in thymus | 2.82e-04 | 13 | 40 | 2 | GO:0033089 | |
| GeneOntologyCellularComponent | uniplex complex | 5.60e-05 | 6 | 41 | 2 | GO:1990246 | |
| GeneOntologyCellularComponent | calcium channel complex | 3.96e-04 | 73 | 41 | 3 | GO:0034704 | |
| Domain | MCU | 4.70e-06 | 2 | 41 | 2 | PF04678 | |
| Domain | Coiled-coil-dom_prot_109_C | 4.70e-06 | 2 | 41 | 2 | IPR006769 | |
| Domain | TB2_DP1_HVA22 | 7.01e-05 | 6 | 41 | 2 | IPR004345 | |
| Domain | TB2_DP1_HVA22 | 7.01e-05 | 6 | 41 | 2 | PF03134 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 4.21e-04 | 14 | 41 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 4.21e-04 | 14 | 41 | 2 | PS00790 | |
| Domain | EphA2_TM | 4.21e-04 | 14 | 41 | 2 | PF14575 | |
| Domain | Tyr_kinase_ephrin_rcpt | 4.21e-04 | 14 | 41 | 2 | IPR016257 | |
| Domain | Eph_TM | 4.21e-04 | 14 | 41 | 2 | IPR027936 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 4.21e-04 | 14 | 41 | 2 | IPR001090 | |
| Domain | Tyr_kinase_rcpt_V_CS | 4.21e-04 | 14 | 41 | 2 | IPR001426 | |
| Domain | EPH_LBD | 4.21e-04 | 14 | 41 | 2 | PS51550 | |
| Domain | EPH_lbd | 4.21e-04 | 14 | 41 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 4.21e-04 | 14 | 41 | 2 | PF01404 | |
| Domain | fn3 | 4.30e-04 | 162 | 41 | 4 | PF00041 | |
| Domain | - | 5.49e-04 | 73 | 41 | 3 | 2.60.120.260 | |
| Domain | FN3 | 7.09e-04 | 185 | 41 | 4 | SM00060 | |
| Domain | FN3 | 9.30e-04 | 199 | 41 | 4 | PS50853 | |
| Domain | TyrKc | 9.47e-04 | 88 | 41 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 9.47e-04 | 88 | 41 | 3 | IPR020635 | |
| Domain | FN3_dom | 1.12e-03 | 209 | 41 | 4 | IPR003961 | |
| Domain | Galactose-bd-like | 1.15e-03 | 94 | 41 | 3 | IPR008979 | |
| Domain | PROTEIN_KINASE_TYR | 1.25e-03 | 97 | 41 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 1.25e-03 | 97 | 41 | 3 | IPR008266 | |
| Domain | Ephrin_rec_like | 1.37e-03 | 25 | 41 | 2 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.37e-03 | 25 | 41 | 2 | IPR011641 | |
| Domain | Glyco_trans_2-like | 1.97e-03 | 30 | 41 | 2 | IPR001173 | |
| Domain | Glycos_transf_2 | 1.97e-03 | 30 | 41 | 2 | PF00535 | |
| Domain | PTPc | 2.83e-03 | 36 | 41 | 2 | SM00194 | |
| Domain | Pkinase_Tyr | 2.83e-03 | 129 | 41 | 3 | PF07714 | |
| Domain | TYR_PHOSPHATASE_PTP | 3.31e-03 | 39 | 41 | 2 | PS50055 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 3.43e-03 | 138 | 41 | 3 | IPR001245 | |
| Domain | PTPase_domain | 3.65e-03 | 41 | 41 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 3.65e-03 | 41 | 41 | 2 | PF00102 | |
| Domain | SAM_2 | 4.01e-03 | 43 | 41 | 2 | PF07647 | |
| Domain | Tyr_Pase_AS | 1.12e-02 | 73 | 41 | 2 | IPR016130 | |
| Domain | ConA-like_dom | 1.22e-02 | 219 | 41 | 3 | IPR013320 | |
| Pathway | REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT | 1.21e-05 | 23 | 28 | 3 | M27816 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 3.74e-05 | 681 | 28 | 8 | MM14985 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | 6.50e-05 | 736 | 28 | 8 | M27287 | |
| Pathway | REACTOME_PROCESSING_OF_SMDT1 | 4.49e-04 | 16 | 28 | 2 | M27819 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.49e-04 | 16 | 28 | 2 | M47695 | |
| Pathway | REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT | 5.08e-04 | 17 | 28 | 2 | MM15541 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 6.37e-04 | 19 | 28 | 2 | M47760 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.18e-03 | 238 | 28 | 4 | MM15076 | |
| Pathway | WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING | 1.39e-03 | 28 | 28 | 2 | M39632 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.39e-03 | 249 | 28 | 4 | M5988 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 1.49e-03 | 29 | 28 | 2 | M27309 | |
| Pathway | PID_EPHA_FWDPATHWAY | 2.05e-03 | 34 | 28 | 2 | M177 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | COX15 ZNF609 REEP4 GALNT7 MCUB MBOAT7 MED16 PEX26 MCU CNTNAP1 | 9.96e-07 | 1203 | 41 | 10 | 29180619 |
| Pubmed | MCUb Induction Protects the Heart From Postischemic Remodeling. | 1.36e-06 | 2 | 41 | 2 | 32299299 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 23911198 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 26828201 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 23900286 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 25676701 | ||
| Pubmed | REEP3 and REEP4 determine the tubular morphology of the endoplasmic reticulum during mitosis. | 1.36e-06 | 2 | 41 | 2 | 30995177 | |
| Pubmed | Segregation of axial motor and sensory pathways via heterotypic trans-axonal signaling. | 1.36e-06 | 2 | 41 | 2 | 18403711 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 37976157 | ||
| Pubmed | Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition. | 4.06e-06 | 3 | 41 | 2 | 36656913 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 7522971 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 21856938 | ||
| Pubmed | EphA3 null mutants do not demonstrate motor axon guidance defects. | 8.12e-06 | 4 | 41 | 2 | 14585969 | |
| Pubmed | Ephrins guide migrating cortical interneurons in the basal telencephalon. | 8.12e-06 | 4 | 41 | 2 | 20473036 | |
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 20398064 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 38514795 | ||
| Pubmed | EMRE is an essential component of the mitochondrial calcium uniporter complex. | 1.35e-05 | 5 | 41 | 2 | 24231807 | |
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 28926625 | ||
| Pubmed | 1.35e-05 | 5 | 41 | 2 | 31533452 | ||
| Pubmed | Embryonic stem cells express multiple Eph-subfamily receptor tyrosine kinases. | 1.35e-05 | 5 | 41 | 2 | 8552593 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 1.87e-05 | 1321 | 41 | 9 | 27173435 | |
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 22275477 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 26063811 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 15996548 | ||
| Pubmed | Area specificity and topography of thalamocortical projections are controlled by ephrin/Eph genes. | 2.03e-05 | 6 | 41 | 2 | 12895420 | |
| Pubmed | 2.84e-05 | 7 | 41 | 2 | 9632142 | ||
| Pubmed | Mistargeting hippocampal axons by expression of a truncated Eph receptor. | 3.78e-05 | 8 | 41 | 2 | 12124402 | |
| Pubmed | 3.78e-05 | 8 | 41 | 2 | 15145949 | ||
| Pubmed | 4.86e-05 | 9 | 41 | 2 | 11403717 | ||
| Pubmed | Topographic guidance labels in a sensory projection to the forebrain. | 4.86e-05 | 9 | 41 | 2 | 9883724 | |
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 25073978 | ||
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 28197551 | ||
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 35302860 | ||
| Pubmed | Inherited ACTH insensitivity illuminates the mechanisms of ACTH action. | 6.07e-05 | 10 | 41 | 2 | 16271481 | |
| Pubmed | RTP family members induce functional expression of mammalian odorant receptors. | 6.07e-05 | 10 | 41 | 2 | 15550249 | |
| Pubmed | Quantitative assessment of computational models for retinotopic map formation. | 6.07e-05 | 10 | 41 | 2 | 25367067 | |
| Pubmed | EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes. | 6.07e-05 | 10 | 41 | 2 | 16547242 | |
| Pubmed | 7.41e-05 | 11 | 41 | 2 | 15517401 | ||
| Pubmed | 7.41e-05 | 11 | 41 | 2 | 22171039 | ||
| Pubmed | Anatomical coupling of sensory and motor nerve trajectory via axon tracking. | 7.41e-05 | 11 | 41 | 2 | 21791286 | |
| Pubmed | 7.41e-05 | 11 | 41 | 2 | 10559410 | ||
| Pubmed | 8.88e-05 | 12 | 41 | 2 | 1281307 | ||
| Pubmed | Ephrin/ephrin receptor expression during early stages of mouse inner ear development. | 8.88e-05 | 12 | 41 | 2 | 21465626 | |
| Pubmed | Expression of PTPRO in the interneurons of adult mouse olfactory bulb. | 8.88e-05 | 12 | 41 | 2 | 19924828 | |
| Pubmed | EphrinA-EphA receptor interactions in mouse spinal neurulation: implications for neural fold fusion. | 8.88e-05 | 12 | 41 | 2 | 19247962 | |
| Pubmed | Eph-ephrin A system regulates murine blastocyst attachment and spreading. | 1.05e-04 | 13 | 41 | 2 | 17039519 | |
| Pubmed | 1.05e-04 | 13 | 41 | 2 | 12528186 | ||
| Pubmed | 1.22e-04 | 14 | 41 | 2 | 26941654 | ||
| Pubmed | Differential gene expression in migratory streams of cortical interneurons. | 1.22e-04 | 14 | 41 | 2 | 22103416 | |
| Pubmed | A role for the EphA family in the topographic targeting of vomeronasal axons. | 1.22e-04 | 14 | 41 | 2 | 11222144 | |
| Pubmed | 1.31e-04 | 83 | 41 | 3 | 11114734 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 1.31e-04 | 420 | 41 | 5 | 28065597 | |
| Pubmed | 1.41e-04 | 15 | 41 | 2 | 36028553 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 1.57e-04 | 697 | 41 | 6 | 28298427 | |
| Pubmed | Ephrin-B2 and EphB1 mediate retinal axon divergence at the optic chiasm. | 1.82e-04 | 17 | 41 | 2 | 12971893 | |
| Pubmed | Sall genes regulate region-specific morphogenesis in the mouse limb by modulating Hox activities. | 1.82e-04 | 17 | 41 | 2 | 19168674 | |
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 1.82e-04 | 17 | 41 | 2 | 12217323 | |
| Pubmed | 2.06e-04 | 733 | 41 | 6 | 34672954 | ||
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 2.29e-04 | 19 | 41 | 2 | 12684176 | |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 2.41e-04 | 102 | 41 | 3 | 15778465 | |
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 10207129 | ||
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 2.54e-04 | 20 | 41 | 2 | 11256076 | |
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 23620790 | ||
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 9576626 | ||
| Pubmed | 2.54e-04 | 20 | 41 | 2 | 9530499 | ||
| Pubmed | 2.81e-04 | 21 | 41 | 2 | 9267020 | ||
| Pubmed | Developmental expression of Eph and ephrin family genes in mammalian small intestine. | 2.81e-04 | 21 | 41 | 2 | 20112066 | |
| Pubmed | Eph receptors and ephrins demarcate cerebellar lobules before and during their formation. | 2.81e-04 | 21 | 41 | 2 | 10495276 | |
| Pubmed | 2.81e-04 | 21 | 41 | 2 | 11128993 | ||
| Pubmed | Eph receptors and ephrins: regulators of guidance and assembly. | 2.81e-04 | 21 | 41 | 2 | 10730216 | |
| Pubmed | Thalamic afferents influence cortical progenitors via ephrin A5-EphA4 interactions. | 3.38e-04 | 23 | 41 | 2 | 25480914 | |
| Pubmed | Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling. | 3.38e-04 | 23 | 41 | 2 | 19542359 | |
| Pubmed | Eph receptors and their ephrin ligands are expressed in developing mouse pancreas. | 3.68e-04 | 24 | 41 | 2 | 16446123 | |
| Pubmed | Regulation of mesenchymal-to-epithelial transition by PARAXIS during somitogenesis. | 3.68e-04 | 24 | 41 | 2 | 24038871 | |
| Pubmed | Identification of tyrosine kinases expressed in the male mouse gubernaculum during development. | 4.00e-04 | 25 | 41 | 2 | 15254900 | |
| Pubmed | 4.05e-04 | 832 | 41 | 6 | 36724073 | ||
| Pubmed | Compensatory Actions of Ldb Adaptor Proteins During Corticospinal Motor Neuron Differentiation. | 7.00e-04 | 33 | 41 | 2 | 26830346 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 9.28e-04 | 38 | 41 | 2 | 30786075 | |
| Pubmed | 9.65e-04 | 650 | 41 | 5 | 38777146 | ||
| Pubmed | 1.03e-03 | 40 | 41 | 2 | 30898150 | ||
| Pubmed | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. | 1.13e-03 | 42 | 41 | 2 | 11439183 | |
| Cytoband | 19q13.4 | 2.30e-03 | 79 | 41 | 2 | 19q13.4 | |
| GeneFamily | Receptor accessory proteins | 4.53e-05 | 6 | 32 | 2 | 717 | |
| GeneFamily | Fibronectin type III domain containing | 1.75e-04 | 160 | 32 | 4 | 555 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 2.73e-04 | 14 | 32 | 2 | 1095 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 6.24e-04 | 21 | 32 | 2 | 813 | |
| GeneFamily | Solute carriers | 4.97e-03 | 395 | 32 | 4 | 752 | |
| GeneFamily | Sterile alpha motif domain containing | 1.06e-02 | 88 | 32 | 2 | 760 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 5.86e-07 | 196 | 41 | 6 | M5381 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Acta2Rgs5.Rgs5_(Mural.Acta2Rgs5.Rgs5)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.99e-06 | 134 | 41 | 4 | 1fa13185a4dfb4563473184c0c4f449011d88631 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Acta2Rgs5.Rgs5_(Mural.Acta2Rgs5.Rgs5)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.99e-06 | 134 | 41 | 4 | 1ab99a22d0d7657f62f8ea7d96bb24e88de54fd4 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.99e-06 | 134 | 41 | 4 | 8a3acf32cabc37b49d6488d43cdaae7cec79d119 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.82e-06 | 146 | 41 | 4 | 69cbe8d4772f8e46a5e1a1cdca0e370308a97b4f | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 165 | 41 | 4 | ba041deb0d9c187f251493ccd4794b5f09abd5aa | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 170 | 41 | 4 | 6e82e41acd1299aa549a32ac036b39754abdf376 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 170 | 41 | 4 | 18cd941bf3ca7cc0b6af1317bd2619d283353de0 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 176 | 41 | 4 | 2e9073166da4d9fae70ba4f3fdcad35523caf7cd | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 183 | 41 | 4 | ee9c88be88221b7ad4ea9f890b17d6156fb3432e | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 183 | 41 | 4 | c52b84034503d931f7b87312d2ff86daff14152d | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 2.44e-05 | 184 | 41 | 4 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | control-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.71e-05 | 189 | 41 | 4 | bdfd120900ba58d5e54765f7b576e1f8cc2401bf | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-large_intestine_goblet_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 189 | 41 | 4 | 5a0fd34928117f162c83ca1b068aa8f7069a6765 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | 95d8dc8488e95158e84a44bb53ea4ab7bf3d44bb | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | 6c6d3259e23ec90c08756f500ae8a7aff8b8a5b3 | |
| ToppCell | droplet-Marrow-nan-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 190 | 41 | 4 | e2fdbfaf08da3274b6bdda615386aa880040a90a | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal-PNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.18e-05 | 197 | 41 | 4 | 10e72b425a2bcba35e63a5b074d3dedcd49a762e | |
| ToppCell | Control-B_memory-3|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.18e-05 | 197 | 41 | 4 | b86385c6c1d52ef4e3d855004d77afab61556978 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.24e-05 | 198 | 41 | 4 | 4e598aab92141e7d32ec963291ddeed14a21beba | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-04 | 130 | 41 | 3 | d47d4ff1263815896470d854d25306eb36919e70 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD4+_T-Treg-Treg_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.32e-04 | 130 | 41 | 3 | ad57b210c96caedadc1027b4d7a56b1bc389b137 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.07e-04 | 143 | 41 | 3 | 8f897278f9ccc82ae35e4f30c5f930b2a3eb509d | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.19e-04 | 145 | 41 | 3 | e932361734839c14ffa0c1e028dcef9c833f884f | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.26e-04 | 146 | 41 | 3 | a4f2e3ea79e7154873c01739672ec6454547e6a6 | |
| ToppCell | facs-Aorta-Heart-24m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 146 | 41 | 3 | d8d24851e8d8d90795a6f9378418f209200d55b1 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.53e-04 | 150 | 41 | 3 | c843bcf98c5fad2ca4339602f721f3fb782ae353 | |
| ToppCell | severe_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 3.67e-04 | 152 | 41 | 3 | ab5a4e47b23d16018642d4c9c7f41b30205edf73 | |
| ToppCell | frontal_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.67e-04 | 152 | 41 | 3 | f9c29d4568402ca07a717dbffb3ccc7f35c5fe56 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-04 | 154 | 41 | 3 | e51a5114f0ec38f997f5b8bbf3a7770f98595474 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.81e-04 | 154 | 41 | 3 | c663e9834be0b45389a862dc3c13a1f988a3e5ee | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.88e-04 | 155 | 41 | 3 | d0c1608f8f6b6f4174e51d610501c707cba5e015 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | d8e283414a770f05d71f0455d0822e9a9660b115 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 157 | 41 | 3 | 165e98bf944572cafbc06ef43c9eab7bd6bea1c2 | |
| ToppCell | severe_COVID-19-NK_CD56bright|severe_COVID-19 / disease group, cell group and cell class (v2) | 4.11e-04 | 158 | 41 | 3 | c2e8d96fc29aa2388b92b4fd81d2726e1f7a053f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-04 | 159 | 41 | 3 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-04 | 159 | 41 | 3 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.18e-04 | 159 | 41 | 3 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-04 | 162 | 41 | 3 | ed9ee98d6568b0ac2cd3af1d58a17364ff2cfa22 | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-T_entry|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.42e-04 | 162 | 41 | 3 | a27750117e7f16a0bd07cc5f58a56becb39e800b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.42e-04 | 162 | 41 | 3 | 6ffcf369d954c20ce036aa1d072cee4e205f728e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.42e-04 | 162 | 41 | 3 | bcbf7f80a2a1c80def795e345f16cf16e8b9d03b | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-04 | 163 | 41 | 3 | 385b24e18df5ef92108483de312d6c85a1e6d145 | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-3|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 4.50e-04 | 163 | 41 | 3 | 0e8d3c98209fc98b86b841d69051cee9e276d837 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-04 | 163 | 41 | 3 | 8004cc0b3428be08b89957b563cd8799f822d931 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.58e-04 | 164 | 41 | 3 | f88871d3b9307112eb7ced4c629f5704326ecae8 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 41 | 3 | e841e62cb20235d6233f78f4155fb8c0ffb1ef1b | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 41 | 3 | bf6c35c3e67ef4ca98a38926c6f7923ecca0508a | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 41 | 3 | 3ca3ddb663644f0e7f70f9b75833bb54cd9191d3 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 41 | 3 | 433128b7d964b32faa0bf437a02facc819ab1405 | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 41 | 3 | f751cbd01d4978ded7755874ab60504f6291afd7 | |
| ToppCell | Severe-Lymphoid-NK-CD8_T|Severe / Condition, Lineage, Cell class and cell subclass | 4.83e-04 | 167 | 41 | 3 | 8d41015871616ab7eced5104cd8f70d0efe504f2 | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-macrophage|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.83e-04 | 167 | 41 | 3 | c2952d8ba763374c5678b92825c8956fc3e3ecd2 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.83e-04 | 167 | 41 | 3 | 063ec29b32e40aaa138a691da3a79ee8eef0c2be | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.83e-04 | 167 | 41 | 3 | f1ce6e64ebede1f3ef36fe982f46919fd1f814dd | |
| ToppCell | facs-MAT-Fat-24m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-04 | 168 | 41 | 3 | 6514a27a54ea0f07172b3a73270250143a7b14f0 | |
| ToppCell | droplet-Fat-Scat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-04 | 168 | 41 | 3 | 749eccebe4ee066f827d2a3980512f195f23ac27 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.91e-04 | 168 | 41 | 3 | cc0dd43d5cda01e643d8e8d74ec7617d61890760 | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-04 | 168 | 41 | 3 | 0b6bb335e93476b13955543eeb487243b0067369 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.91e-04 | 168 | 41 | 3 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | facs-SCAT-Fat-18m-Myeloid-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | 4d783e27fd7d25d9c157b98ae7df55acb1e72d4b | |
| ToppCell | facs-SCAT-Fat-18m-Myeloid-myeloid_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | 1e34a13a450f90b79fcaacd72ad3a7aa21e5eed2 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | 91cfff1ad559cc327c6bb71c98aa29f0b3642568 | |
| ToppCell | facs-GAT-Fat-18m-Myeloid|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | 0e1a99cd77edcf32bcb513abd247b2b27409ac63 | |
| ToppCell | facs-SCAT-Fat-18m-Myeloid|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | dbc6f95b4a0d9bc2a34f649161b83979e5e6fb8e | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | 972618e684321060c7af2429f853a6d639e8aae8 | |
| ToppCell | facs-GAT-Fat-18m-Myeloid-myeloid_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | 9bbad31ef03078f5aa456f2e1b17b49c91545ff0 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | 8e5e513090e86ca29fb61dfd388014774c506914 | |
| ToppCell | facs-GAT-Fat-18m-Myeloid-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-04 | 169 | 41 | 3 | 7a7416fcbffcf57d19b477d9da091e04e3499524 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.08e-04 | 170 | 41 | 3 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.17e-04 | 171 | 41 | 3 | 539ea88acc6f948efdeae8b69e5c5ffaee29f1d9 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-mature_NK_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-04 | 171 | 41 | 3 | d322cc042a6f4b4aa8ef80ae977edbce9e266d48 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 172 | 41 | 3 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 172 | 41 | 3 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.26e-04 | 172 | 41 | 3 | 41ddfb316429efef5f3fa0b0621ced383d9206f0 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-T_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.26e-04 | 172 | 41 | 3 | 0fc692be845d4225ff8b63bf9195724fc8510c2c | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-04 | 172 | 41 | 3 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | Immune_cells-Monocytes|Immune_cells / Lineage and Cell class | 5.35e-04 | 173 | 41 | 3 | 3eced40a65453a023a1673658592e7e2a099119b | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.44e-04 | 174 | 41 | 3 | c52aed2ffe9c648e5f23e3459e2d331d6ca214e3 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.44e-04 | 174 | 41 | 3 | 118ba2729ecc6aa1bb8548f3cf537b3f9e902ef0 | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.53e-04 | 175 | 41 | 3 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.53e-04 | 175 | 41 | 3 | 510c46bfd250ef83fcad8f6b01efbcca9d71a9a2 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.62e-04 | 176 | 41 | 3 | e08e7a6dd0208acfbb8646d71915af822a64b5de | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.62e-04 | 176 | 41 | 3 | bb41e9478373726eb460af764de0277b2d09928e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.62e-04 | 176 | 41 | 3 | b8264cdda75c5145d8bf8ae00b3e05393fe9a92b | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.62e-04 | 176 | 41 | 3 | 9d4a4dfeebb5a8a0f3ab18c37c8ddc2cd2158575 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-NK_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.62e-04 | 176 | 41 | 3 | f0c01fc4f9c17c4d724642d9931731eef2b10258 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.62e-04 | 176 | 41 | 3 | 4aee9fdada077db7e531684ab938153f84dc8146 | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-04 | 176 | 41 | 3 | 77c6103639acd0f3d6a2171c5f37a8083b6c2cf0 | |
| ToppCell | E12.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.72e-04 | 177 | 41 | 3 | 5cdf413f82376a95467322b16d10b0d1e7557e2d | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.72e-04 | 177 | 41 | 3 | f1efd9c3074d5635700fe7fbebf3dd0b1e0a84f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.72e-04 | 177 | 41 | 3 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | Immune_cells-T_cells|Immune_cells / Lineage and Cell class | 5.81e-04 | 178 | 41 | 3 | af420242277e2a4e2524002a2914b0538f79a134 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.81e-04 | 178 | 41 | 3 | f7f88879a05b2b5fa92cf5317b76f7a3064d1358 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.81e-04 | 178 | 41 | 3 | 731e1e8eff2c4018c75dfc66632a316010a09a9a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.91e-04 | 179 | 41 | 3 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.91e-04 | 179 | 41 | 3 | ecea75c568911ff56939c9f67ab901497bd4356c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.00e-04 | 180 | 41 | 3 | 2ae39e26a8e7d5d4d3e1e71609a8ec36fd9855aa | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-04 | 181 | 41 | 3 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | LV-17._Lymphocyte|LV / Chamber and Cluster_Paper | 6.10e-04 | 181 | 41 | 3 | 81fafa69c8c240250a667a5f3b321e8be1b9a288 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-04 | 181 | 41 | 3 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| Drug | Thiamphenicol [15318-45-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 5.33e-08 | 195 | 41 | 7 | 1704_DN | |
| Drug | Zoxazolamine [61-80-3]; Down 200; 23.8uM; MCF7; HT_HG-U133A | 2.75e-05 | 198 | 41 | 5 | 5390_DN | |
| Drug | nocodazole; Down 200; 1uM; MCF7; HG-U133A | 2.75e-05 | 198 | 41 | 5 | 621_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.81e-05 | 199 | 41 | 5 | 3203_DN | |
| Drug | Haloperidol [52-86-8]; Down 200; 10.6uM; HL60; HG-U133A | 2.88e-05 | 200 | 41 | 5 | 2039_DN | |
| Disease | venous thromboembolism, factor VII measurement | 1.88e-05 | 38 | 40 | 3 | EFO_0004286, EFO_0004619 | |
| Disease | hereditary spastic paraplegia 31 (implicated_via_orthology) | 2.68e-05 | 6 | 40 | 2 | DOID:0110782 (implicated_via_orthology) | |
| Disease | response to mepolizumab, Glucocorticoid use measurement | 2.70e-04 | 18 | 40 | 2 | EFO_0008459, EFO_0009942 | |
| Disease | disease | 3.70e-04 | 21 | 40 | 2 | EFO_0000408 | |
| Disease | Drugs used in diabetes use measurement | 3.90e-04 | 255 | 40 | 4 | EFO_0009924 | |
| Disease | Immunologic Deficiency Syndromes | 4.45e-04 | 23 | 40 | 2 | C0021051 | |
| Disease | alcohol consumption measurement | 1.27e-03 | 1242 | 40 | 7 | EFO_0007878 | |
| Disease | diastolic blood pressure change measurement | 2.11e-03 | 50 | 40 | 2 | EFO_0006945 | |
| Disease | cutaneous melanoma, hair color | 3.22e-03 | 62 | 40 | 2 | EFO_0000389, EFO_0003924 | |
| Disease | systemic lupus erythematosus | 4.32e-03 | 799 | 40 | 5 | MONDO_0007915 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 5.30e-03 | 80 | 40 | 2 | DOID:6432 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FNSWDWVTRYMLLYG | 91 | P78357 | |
| CYFVRYWITEFWVMF | 126 | O95267 | |
| PYYMWDYVARWFEEC | 431 | Q5JWR5 | |
| RWVWISLYYVAFYVV | 36 | P51164 | |
| WVYSWDIMEPVTYFI | 241 | Q9NWR8 | |
| WEYSWDIMEPVTYFI | 256 | Q8NE86 | |
| MQRDFRWLWVYEIGY | 1 | Q16206 | |
| DDRIVFWTWMFSTYF | 26 | Q6ICG6 | |
| DVWSYGIVMWEVMSY | 806 | P54764 | |
| MDRWQEVLSWVLQYY | 96 | Q7Z412 | |
| DWVHWFLKMRAYDYM | 396 | Q96N66 | |
| MRWALAWSFYDDVTV | 281 | Q86W50 | |
| AFWIFSWEYAMMYVG | 221 | Q9H490 | |
| DLFMVWDWSTYLADY | 726 | Q8TAG9 | |
| FLLEYCMVTGYDWWD | 476 | Q9Y2X0 | |
| AWYYNFRVTMVTWGD | 601 | Q16827 | |
| AVLYYEETKSFLWWT | 311 | Q96A29 | |
| VRVVEVWWDEYKDYF | 466 | Q86SF2 | |
| DVWSYGIVLWEVMSY | 806 | P29320 | |
| AMRIFEDYTVSWYWI | 221 | Q8IWA5 | |
| YDSWISFLSSVRYWM | 251 | O00219 | |
| EFKFIWYMEYSHRMW | 141 | Q7KZN9 | |
| NIREYVRWMMYWIVF | 31 | Q9H6H4 | |
| TYYWEVEIIEGWVSM | 481 | Q96LD4 | |
| DYVTVRKDAYMFWWL | 41 | Q9HB40 | |
| WFRTYMWGVIYLRNV | 756 | Q8IV36 | |
| VRWMMYWIVFALYTV | 36 | Q6NUK4 | |
| LVEWRIWYMKDTSLY | 31 | H7C241 | |
| TWYEYTWDSQRMLDE | 481 | Q9NQW8 | |
| YEEEMLATKYALWWS | 201 | Q12884 | |
| ALWEVMLSYYRTMEW | 331 | Q96JG6 | |
| DVWSYGVTMWEALSY | 521 | P43403 | |
| LDYVMCDYRSEGWWT | 476 | Q7Z392 | |
| SYVWKMYQERCWDFF | 4841 | Q15413 | |
| WYRQEAEPRMWTYVY | 1131 | O15014 | |
| NDRWRFYWKMVYEYA | 286 | Q5GH76 | |
| DLYSESLIMDWWYNA | 696 | Q502W6 | |
| LLMAVFSEKLDYYWW | 191 | Q15849 | |
| YSYWVSWVREGMTDP | 506 | Q9HD43 | |
| TFYCISMQWFREWES | 846 | Q8TEY7 | |
| TAAWSIFAYIWLYMI | 206 | P57103 |